Modern medicine is dependent on chemotherapeutic agents, chemical agents that are used to treat diseases. Chemotherapeutic agents destroy pathogenic microorganisms or inhibit their growth at concentrations low enough to avoid undesirable damage to the host. Most of these agents are antibiotics (anti: against, biotic: bios, life), microbial products or their derivatives that can kill susceptible microorganisms or inhibit their growth.
The first antibiotic penicillin was discovered and developed in 1896 by a 21-year-old French medical student named Ernest Duchnense, his work was forgotten, and the Scotish physician Alexander Flemming rediscovered penicillin. The discovery of penicillin stimulated the search for other antibiotics. Selman Waksman announced in 1944 that he had found new antibiotic, streptomycin, produced by the actinomycete Strptomyces griseus.
Antibiotics vary in their range of effectiveness. Many are narrow spectrum- that is they are effective only against limited variety of pathogens. Other is broad spectrum and attack many different kinds of pathogens.
Chemotherapeutic agents can be synthesized independent of microorganism or manufactured by chemical procedures independent of microbial activity. A number of most commonly employed antibiotics are natural- that is totally synthesized by one of a few bacteria or fungi.
Microbial Sources of Antibiotics |
|
Microorganism |
Antibiotic |
Bacteria Micromonospora spp. |
� Amphotericin B, Chloramphenicol (synthetic also), Erythromycin, Kanamycin, Neomycin, Nystatin, Rifampin, Streptomycin, Tetracyclines, Vancomycin |
Fungi |
� Griseofulvin, Penicillin |
Drug |
Mechanism |
Cell wall synthesis Inhibition Bacitracin |
� Inhibit transpeptidation enzymes involved in the cross linking of the polysaccharide chains of the bacterial cell wall peptidoglycan. Activate cell wall lytic enzymes. |
Protein Synthesis Inhibition Chloramphenicol Tetracyclines Erythromycin and Clindamycin Fusidic acid |
� Binds with the 30s subunit of the bacterial ribosome to inhibit protein synthesis and causes misreading of mRNA. Bind to the 50s ribosomal subunit and inhibit chain elongation. Binds to EF-G and blocks translocation. |
Nucleic Acid Synthesis Inhibiton |
� Inhibit bacterial DNA gyrase and thus interfere with DNA replication, transcription, and other activities involving DNA. |
Cell membrane Disruption |
� Binds to the plasma membrane and disrupts its structure and permeability properties. |
Metabolic Antagonism Trimethoprim |
� Inhibit folic acid synthesis by competition with p-aminobenzoic acid. |